ArticleFrontiers in oncology2023

A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses.

Wenlong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.